(19)
(11) EP 3 570 924 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
11.10.2023 Bulletin 2023/41

(45) Mention of the grant of the patent:
06.09.2023 Bulletin 2023/36

(21) Application number: 18701542.5

(22) Date of filing: 18.01.2018
(51) International Patent Classification (IPC): 
A61M 25/00(2006.01)
 A61M 25/10(2013.01)
(52) Cooperative Patent Classification (CPC):
A61M 25/0017; A61M 25/1034; A61M 25/0015; A61M 25/1002; A61M 25/1029; A61M 25/1036
(86) International application number:
PCT/GB2018/050136
(87) International publication number:
WO 2018/134591 (26.07.2018 Gazette 2018/30)

(54)

URINARY CATHETER

HARNGANGKATHETER

CATHÉTER URINAIRE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 20.01.2017 GB 201701027

(43) Date of publication of application:
27.11.2019 Bulletin 2019/48

(73) Proprietor: The Flume Catheter Company Limited
Farnham, Surrey GU10 3EE (GB)

(72) Inventors:
  • HAVARD, John
    Saxmundham Suffolk IP17 2BH (GB)
  • HOLMES, Roger
    Saxmundham Suffolk IP17 2BH (GB)

(74) Representative: Slingsby Partners LLP 
1 Kingsway
London WC2B 6AN
London WC2B 6AN (GB)


(56) References cited: : 
EP-A1- 1 142 530
US-A- 3 438 375
 WO-A1-2017/158081
US-A- 3 954 110
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).